Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer

William S. Chen, Eric L. Feng, Rahul Aggarwal, Adam Foye, Tomasz M. Beer, Joshi J. Alumkal, Martin Gleave, Kim N. Chi, Robert E. Reiter, Matthew B. Rettig, Christopher P. Evans, Eric J. Small, Nima Sharifi, Shuang G. Zhao

    Research output: Contribution to journalArticlepeer-review

    1 Scopus citations

    Abstract

    Introduction: Germline variants in androgen metabolism genes may influence clinical response to androgen deprivation therapy (ADT) in advanced prostate cancer. We sought to investigate the prognostic significance of germline variants in androgen metabolism genes with respect to overall survival (OS) after ADT, and to associate germline variants with tumor genomic features. Methods: Germline and somatic whole-genome sequencing (WGS) data were evaluated in a cohort of 101 men with metastatic castration-resistant prostate cancer (mCRPC). Survival analyses were performed to identify polymorphisms associated with impaired OS after primary ADT. Germline variants found to be prognostic of OS were associated with tumor somatic DNA-sequence alterations based on WGS performed on paired metastasis biopsies from the same 101 patients. Gene set enrichment analysis was performed based on tumor RNA-sequencing data to identify genomic pathways differentially expressed in patients with germline variants. Results: A comprehensive literature review identified 17 candidate polymorphisms in nine androgen metabolism genes that have been previously shown to have an association with response to ADT in prostate cancer. Of these, the variant rs1856888 allele located 13 kb upstream of HSD3B1 was found to be significantly associated with impaired OS (P = 0.029). Variant rs1856888 was commonly co-inherited with the well-characterized HSD3B1(1245A>C) polymorphism, and there was a trend toward shorter median OS in patients with HSD3B1(1245A>C) compared with homozygous wild-type patients (P = 0.052). While HSD3B1 germline variants were not associated with common somatic tumor DNA alterations, they were associated with increased tumor expression of cell proliferation and cell cycle genes. Conclusions: This study presents a comprehensive assessment of germline variants in androgen metabolism genes and highlights HSD3B1 polymorphisms as prognostic of OS after ADT and associated with an aggressive gene expression tumor profile in mCRPC.

    Original languageEnglish (US)
    Pages (from-to)316-323
    Number of pages8
    JournalProstate Cancer and Prostatic Diseases
    Volume23
    Issue number2
    DOIs
    StatePublished - Jun 1 2020

    ASJC Scopus subject areas

    • Oncology
    • Urology
    • Cancer Research

    Fingerprint Dive into the research topics of 'Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer'. Together they form a unique fingerprint.

    Cite this